Dendritic Cell Therapy With CD137L-DC-EBV-VAX in Locally Advanced Stage IV or Locally Recurrent/Metastatic Nasopharyngeal Carcinoma
Clinical trial NCT03282617 · UNKNOWN
Trial details
- NCT number
- NCT03282617
- Sponsor
- National University Hospital, Singapore
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-14
- Primary completion
- 2019-08-14
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.